Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial ATP synthase F1 subunit beta (ATP5F1B) is a critical component of the F1 sector of the F1Fo-ATP synthase complex, also known as Complex V of the mitochondrial respiratory chain (UniProt). This subunit contains the catalytic site responsible for the synthesis of ATP from ADP and inorganic phosphate, driven by the proton motive force across the inner mitochondrial membrane (Wikipedia). Beyond its central role in bioenergetics, ATP5F1B is found ectopically on the plasma membrane of certain cells, where it acts as a receptor for various ligands, including angiostatin and high-density lipoproteins (PubMed). In cancer, the overexpression or cell-surface translocation of this subunit is associated with increased metastasis and poor prognosis, making it an attractive target for anti-angiogenic and anti-tumor therapies (NIH). Mutations in the ATP5F1B gene are linked to mitochondrial diseases such as complex V deficiency and neurodegenerative conditions like dystonia (PubMed). Pharmacological modulation of the beta subunit by inhibitors like aurovertin B or dietary polyphenols can disrupt cellular energy metabolism, though systemic inhibition poses significant safety risks due to the enzyme's essential role in all aerobic cells (NIH).
Inhibition of the catalytic activity of the F1 sector by binding to the beta subunit or the alpha/beta interface, thereby blocking the rotational mechanism or the binding of ADP/ATP, which halts ATP synthesis and hydrolysis.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase F(1) complex catalytic subunit beta, mitochondrial (ATP5F1B).